InvestorsHub Logo
Followers 0
Posts 1283
Boards Moderated 0
Alias Born 07/28/2019

Re: locicat1 post# 13050

Saturday, 03/21/2020 9:27:52 PM

Saturday, March 21, 2020 9:27:52 PM

Post# of 18220
I don’t like to respond to your questions“FDA to discuss the phase III clinical program for ITX401 treatment of pancreatic cancer. IMUN also expects to initiate testing on the use of Lodonal™ and ITX401 with other approved cancer drugs like Keytruda® and Opvido® in partnership with CYTO to determine the probability of enhancing the safety and efficacy of these already approved cancer drugs.”

Keytruda is inhibitory antibodies